H. Jeffrey Wilkins serves as Executive at Zyla Life Sciences, where they oversee executive responsibilities. Since joining the company, H. Jeffrey Wilkins has executed 3 insider transactions totaling $12.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 10, 2021 involved purchasing 6,371 shares valued at $10.0K.
H. Jeffrey Wilkins currently holds 33,373 shares of Zyla Life Sciences (ZCOR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, H. Jeffrey Wilkins has been a net buyer of ZCOR stock. They have purchased $12.1K and sold $0 worth of shares.
H. Jeffrey Wilkins's most recent insider trade was on Dec 10, 2021, when they purchased 6,371 shares at $1.57 per share.
Get notified when new Form 4 filings are submitted
| $2.28 |
| Discretionary |
| Jul 1, 2019 | ZCOR | $0 | Award | 190,000 | $N/A | Discretionary |